BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16276165)

  • 1. Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial.
    Morelli A; Ricci Z; Bellomo R; Ronco C; Rocco M; Conti G; De Gaetano A; Picchini U; Orecchioni A; Portieri M; Coluzzi F; Porzi P; Serio P; Bruno A; Pietropaoli P
    Crit Care Med; 2005 Nov; 33(11):2451-6. PubMed ID: 16276165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
    Brienza N; Malcangi V; Dalfino L; Trerotoli P; Guagliardi C; Bortone D; Faconda G; Ribezzi M; Ancona G; Bruno F; Fiore T
    Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial.
    Tumlin JA; Finkel KW; Murray PT; Samuels J; Cotsonis G; Shaw AD
    Am J Kidney Dis; 2005 Jul; 46(1):26-34. PubMed ID: 15983954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial.
    Bove T; Zangrillo A; Guarracino F; Alvaro G; Persi B; Maglioni E; Galdieri N; Comis M; Caramelli F; Pasero DC; Pala G; Renzini M; Conte M; Paternoster G; Martinez B; Pinelli F; Frontini M; Zucchetti MC; Pappalardo F; Amantea B; Camata A; Pisano A; Verdecchia C; Dal Checco E; Cariello C; Faita L; Baldassarri R; Scandroglio AM; Saleh O; Lembo R; CalabrĂ² MG; Bellomo R; Landoni G
    JAMA; 2014 Dec; 312(21):2244-53. PubMed ID: 25265449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
    Stone GW; McCullough PA; Tumlin JA; Lepor NE; Madyoon H; Murray P; Wang A; Chu AA; Schaer GL; Stevens M; Wilensky RL; O'Neill WW;
    JAMA; 2003 Nov; 290(17):2284-91. PubMed ID: 14600187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial.
    O'Hara JF; Mahboobi R; Novak SM; Bonilla AM; Mascha EJ; Fergany AF; Campbell SC; Kaouk JH; Kaple KM; Gill IS; Ziegman SA; Sessler DI
    Urology; 2013 Feb; 81(2):340-5. PubMed ID: 23374797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy.
    Tumlin JA; Wang A; Murray PT; Mathur VS
    Am Heart J; 2002 May; 143(5):894-903. PubMed ID: 12040355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis.
    Landoni G; Biondi-Zoccai GG; Marino G; Bove T; Fochi O; Maj G; CalabrĂ² MG; Sheiban I; Tumlin JA; Ranucci M; Zangrillo A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):27-33. PubMed ID: 18249327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting.
    Halpenny M; Lakshmi S; O'Donnell A; O'Callaghan-Enright S; Shorten GD
    Anaesthesia; 2001 Oct; 56(10):953-60. PubMed ID: 11576097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent.
    Samuels J; Finkel K; Gubert M; Johnson T; Shaw A
    Ren Fail; 2005; 27(1):101-5. PubMed ID: 15717642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects.
    Mathur VS; Swan SK; Lambrecht LJ; Anjum S; Fellmann J; McGuire D; Epstein M; Luther RR
    Crit Care Med; 1999 Sep; 27(9):1832-7. PubMed ID: 10507606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenoldopam in critically ill patients with early renal dysfunction. A crossover study.
    Cobas M; Paparcuri G; De La Pena M; Cudemus G; Barquist E; Varon A
    Cardiovasc Ther; 2011 Aug; 29(4):280-4. PubMed ID: 20955210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial.
    Bove T; Landoni G; CalabrĂ² MG; Aletti G; Marino G; Cerchierini E; Crescenzi G; Zangrillo A
    Circulation; 2005 Jun; 111(24):3230-5. PubMed ID: 15967861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prophylactic fenoldopam infusion on renal blood flow and renal tubular function during acute hypovolemia in anesthetized dogs.
    Halpenny M; Markos F; Snow HM; Duggan PF; Gaffney E; O'Connell DP; Shorten GD
    Crit Care Med; 2001 Apr; 29(4):855-60. PubMed ID: 11373482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery.
    Barr LF; Kolodner K
    Crit Care Med; 2008 May; 36(5):1427-35. PubMed ID: 18434903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients.
    Ranucci M; Soro G; Barzaghi N; Locatelli A; Giordano G; Vavassori A; Manzato A; Melchiorri C; Bove T; Juliano G; Uslenghi MF
    Ann Thorac Surg; 2004 Oct; 78(4):1332-7; discussion 1337-8. PubMed ID: 15464494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass.
    Caimmi PP; Pagani L; Micalizzi E; Fiume C; Guani S; Bernardi M; Parodi F; Cordero G; Fregonara M; Kapetanakis E; Panella M; Degasperis C
    J Cardiothorac Vasc Anesth; 2003 Aug; 17(4):491-4. PubMed ID: 12968238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery.
    Roasio A; Lobreglio R; Santin A; Landoni G; Verdecchia C
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):23-6. PubMed ID: 18249326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of fenoldopam to control renal dysfunction early after liver transplantation.
    Biancofiore G; Della Rocca G; Bindi L; Romanelli A; Esposito M; Meacci L; Urbani L; Filipponi F; Mosca F
    Liver Transpl; 2004 Aug; 10(8):986-92. PubMed ID: 15390323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials.
    Zangrillo A; Biondi-Zoccai GG; Frati E; Covello RD; Cabrini L; Guarracino F; Ruggeri L; Bove T; Bignami E; Landoni G
    J Cardiothorac Vasc Anesth; 2012 Jun; 26(3):407-13. PubMed ID: 22459931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.